113 related articles for article (PubMed ID: 747138)
1. Clinical experiments with brain cortex phospholipids in psychogeriatrics.
Castellani A; Colafelice M; Perbellini D; Fichera M; Carbognin G; Salvi G; Marsiai M; Rigoli GF
Acta Neurol (Napoli); 1978; 33(3):217-29. PubMed ID: 747138
[No Abstract] [Full Text] [Related]
2. [Phospholipids as coadjuvants in therapy of arteriosclerotic psychoses. Clinical, electroencephalographic and rheographic observations].
Bovi A; Martelli G
Clin Eur; 1965; 4(4):280-8. PubMed ID: 5845619
[No Abstract] [Full Text] [Related]
3. [Senile, presenile and arteriosclerotic dementia. Psychological and laboratory aspects studied in the light of treatment with neurohomologous phospholipids].
Colafelice M; Castellani A; Perbellini D
Acta Neurol (Napoli); 1977; 32(3):332-9. PubMed ID: 883527
[No Abstract] [Full Text] [Related]
4. Hydergine for cerebral arteriosclerosis.
Med Lett Drugs Ther; 1974 Mar; 16(5):21-2. PubMed ID: 4204775
[No Abstract] [Full Text] [Related]
5. [Relations between phospholipids and cholesterol. Intravenous phospholipid administration and therapeutic prospects in atherosclerosis].
Montanari M; Dioli GL; Curri SB
Minerva Med; 1966 Nov; 57(93):3911-7. PubMed ID: 5926203
[No Abstract] [Full Text] [Related]
6. [Rheographic evaluation of the cerebral angio-hemodynamic effects of cytidine diphosphate choline in arteriosclerotic ictal syndromes].
De Gregorio G; Armeli G; Restivo S; Francolino A
Boll Soc Ital Cardiol; 1977; 22(3):341-5. PubMed ID: 617280
[No Abstract] [Full Text] [Related]
7. [Effect of cocarboxylase on cerebral circulation of patients with cerebral arteriosclerosis].
Eninia GI; Smeltere ES
Vrach Delo; 1974 Dec; (12):17-20. PubMed ID: 4446520
[No Abstract] [Full Text] [Related]
8. [The dynamics of the cerebral circulation and of brain functional activity in patients with initial atherosclerotic encephalopathy under the influence of a single intravenous administration of sermion].
Mints AIa; Karaban' IN; Litvinenko AA
Farmakol Toksikol; 1991; 54(4):59-62. PubMed ID: 1786832
[TBL] [Abstract][Full Text] [Related]
9. [Effect of aminalon electrophoresis on brain bioelectrical activity in cerebral atherosclerosis patients with disordered cerebral blood circulation].
Danilova IN; Neretin VIa; Nesterova LA
Vopr Kurortol Fizioter Lech Fiz Kult; 1980; (4):13-7. PubMed ID: 7415011
[No Abstract] [Full Text] [Related]
10. [Clinical trial of nicamethate in psychogeriatrics].
Bianchi G
Clin Ter; 1970 Sep; 54(6):541-52. PubMed ID: 5527648
[No Abstract] [Full Text] [Related]
11. [On the circulatory physiology and biochemistry of cerebral degeneration processes and influencing the behavior of patients with drug therapy].
Cornu F
Wien Klin Wochenschr; 1969 Jun; 81(23):426-31. PubMed ID: 5790194
[No Abstract] [Full Text] [Related]
12. [Effect of calcium pangamate on the cholesterol index of atherogenicity in cerebral arteriosclerosis patients].
Rastopchin IP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):1020-3. PubMed ID: 6475410
[TBL] [Abstract][Full Text] [Related]
13. [The effect of sermion on the main hemodynamic indices in patients with the initial manifestations of cerebral atherosclerosis].
Tokar' AV; Akhaladze NG; Ena LM; Rudaia ES; Severova NL
Vrach Delo; 1990 Feb; (2):27-30. PubMed ID: 2339544
[TBL] [Abstract][Full Text] [Related]
14. [Wallerox increases cerebral circulation and heart capacity].
Heynen U
Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
[No Abstract] [Full Text] [Related]
15. Cerebral blood flow in patients with cerebrovascular disorders: study with pentoxifylline.
Hartmann A
Ric Clin Lab; 1981; 11 Suppl 1():243-6. PubMed ID: 7188111
[TBL] [Abstract][Full Text] [Related]
16. [Effect of antianginal agents on the cerebral circulatory indices in cerebral arteriosclerosis].
Eninia GI; Smeltere ES; Godlevska MA; Logina IP
Klin Med (Mosk); 1985 Sep; 63(9):45-8. PubMed ID: 4068626
[No Abstract] [Full Text] [Related]
17. [Clinical trial of a cattle brain, phospholipid complex in cerebral ischemia syndromes].
Cloetens W; Creatallaz JC; Depaepe A; Bertholet G
Brux Med; 1969 Aug; 49(8):491-9. PubMed ID: 5408513
[No Abstract] [Full Text] [Related]
18. [Clinical experiences with the vascular action of dihydroergocristine].
Tomasi AM; Baggioni GF; Pozzar C
Minerva Cardioangiol; 1975 Jan; 23(1):7-19. PubMed ID: 806854
[No Abstract] [Full Text] [Related]
19. [Action of purified phospholipids on the serum lipid pattern].
Tralli G
Clin Ter; 1977 Mar; 80(6):545-51. PubMed ID: 862355
[No Abstract] [Full Text] [Related]
20. [Can disorders of cerebral performance be improved by drugs? Use of vaso- and metabolically active substances in primary degenerative brain diseases and cerebral arteriosclerosis].
Herrschaft H
Fortschr Med; 1987 Nov; 105(32):637-40. PubMed ID: 3323002
[No Abstract] [Full Text] [Related]
[Next] [New Search]
